ARCHIVES

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | November 27, 2009

Download PDF Visit The Full Archive

Related Articles

NCI Tells How It Would Spend FY 1978 Research Money

June 25, 1976

In Brief: New San Antonio Center Wins Core Grants; ASCO forming A Technology Assessment Committee

July 19, 1991

Fermilab Treats 1,000th Patient

August 7, 1981

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

October 31, 2014

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991

Master’s Program In Nurse Oncology Kept Alive; Final Decisions In February

October 21, 1977